On June 3-5th, ASBM exhibited at the American Society of Clinical Oncologists (ASCO) Annual Meeting in Chicago, IL. There ASBM Chairman Harry L. Gewanter, MD spoke with many physicians, patient advocates and manufacturers about ASBM’s worldwide advocacy on behalf of patients. ASBM shared a booth with Steering Committee member Global Colon Cancer Association, represented by its Executive Director, Andrew Spiegel. Several other ASBM member groups exhibited as well including: the Kidney Cancer Association (KCA), and the International Cancer Advocacy Network (ICAN).
On June 4th-6th, ASBM also exhibited at the American Society of Health System Pharmacists (ASHP) 2017 Summer Meeting in Minneapolis, MN. ASBM Advisory Board Chair Philip Schneider (a past president of ASHP) was at ASBM’s booth.
Dean Schneider visited with many pharmacists from hospitals and health systems nationwide discussing ASBM’s work with the WHO and state governments regarding clear product identification and improved pharmacovigilance. A video aimed at pharmacists, featuring Schneider and fellow Advisory Board member Ronald P. Jordan, Dean of Chapman University’s School of Pharmacy (past president of the American Pharmacists Association), was presented in ASBM’s booth throughout the conference.